is saxenda and semaglutide the same Vs Liraglutide | Wegovy Vs Saxenda vs. Wegovy: Differences, similarities
Description
PATHOGENESIS The pathogenesis of AN in diabetes is multifactorial

The treatment of human SH-SY5Y cells with exenatide has been shown to increase the numbers of neurite-bearing cells, in addition to the actual number of neurites per cell
Current evidence suggests that patients losing weight should consume adequate protein daily, with targets typically ranging from 1.21.6 grams of protein per kilogram of body weight, individualized based on age, activity level, and kidney function

Clinical trials show that gastrointestinal side effectsnausea, vomiting, and constipationoccur in up to 2540% of patients, with severity often correlating to dose escalation speed

Most patients describe this experience as gentle, not disruptive, and many report it as reassuring proof the medication is working
Its also FDA-approved for reducing cardiovascular risks in adults with type 2 diabetes and heart disease, offering a holistic approach to health management
